聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 45 分钟 38 秒 前

New "See-and-Treat" Truclear(TM) Hysteroscope Improves Options for Office Hysteroscopy

周三, 03/09/2016 - 15:01
LONDON, March 9, 2016 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announced the launch of the TRUCLEAR 5C Hysteroscope Set for the combined diagnosis and removal of abnorm...
Devices, Product Launch
Smith & Nephew, TRUCLEAR, Hysteroscope

BME Launches The New Elite(R) Nitinol Bone Fixation System - Transcending Traditional Fixation

周三, 03/09/2016 - 14:58
SAN ANTONIO, March 9, 2016 -- (Healthcare Sales & Marketing Network) -- BioMedical Enterprises, Inc. (BME), the leader in Nitinol fixation technology, announced today the launch of the new BME Elite® Nitinol Bone Fixation System. Working closely with ...
Devices, Orthopaedic, Product Launch
BioMedical Enterprises, BME Elite, Nitinol, Bone Fixation

NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan

周三, 03/09/2016 - 14:49
Largest and Fastest Growing International Market Readies for Introduction of iGA(TM) Platform to Address Spinal Alignment and Drive Improved Long-Term Patient Outcomes SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a lea...
Devices, Orthopaedic, Neurosurgery, Regulatory
NuVasive, Posterior Fixation, Integrated Global Alignment

Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million

周三, 03/09/2016 - 14:45
STOCKHOLM, March 9, 2016 -- (Healthcare Sales & Marketing Network) -- Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Aprea AB has successfully raised SEK 437 million ($51 million) in a Series B financing roun...
Biopharmaceuticals, Oncology, Venture Capital
Aprea AB, Karolinska Development, p53

Arbutus Appoints Dr. Elizabeth Howard Executive Vice President and General Counsel

周二, 03/08/2016 - 15:23
Strengthens Emphasis on Intellectual Property VANCOUVER, British Columbia and DOYLESTOWN, Pa., March 08, 2016 -- (Healthcare Sales & Marketing Network) -- Arbutus Biopharma Corporation (ABUS), an industry-leading therapeutic solutions company focused on...
Biopharmaceuticals, Personnel
Arbutus Biopharma, hepatitis B virus

Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development

周二, 03/08/2016 - 15:20
Dr. Wong to Bring Over 15 Years of Experience in Pharmaceutical Business Development to the Company BROOMFIELD, Colo., March 8, 2016 -- (Healthcare Sales & Marketing Network) -- Accera, Inc., a clinical-stage biotechnology company focused on product de...
Biopharmaceuticals, Neurology, Personnel
Accera, Axona , Alzheimer's disease

ImmunoMet Therapeutics Raises $5.2 million in a Series A Financing

周二, 03/08/2016 - 15:14
Funding to Advance Oncology Development Programs Focused on Cancer Metabolism and Immuno-Oncology Jae Joon Kim Appointed to Board of Directors HOUSTON and DAEJEON, South Korea, March 8, 2016 -- (Healthcare Sales & Marketing Network) -- ImmunoMet The...
Biopharmaceuticals, Oncology, Personnel, Venture Capital
ImmunoMet Therapeutics, glioblastoma

Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls

周二, 03/08/2016 - 15:11
PHILADELPHIA, PA--(Healthcare Sales & Marketing Network) - Medgenics, Inc. (NYSE MKT: MDGN) today announced the appointment of Rick Couch, Ph.D., as Vice President of Chemistry, Manufacturing and Controls (CMC). In this role, Dr. Couch will be a key member...
Biopharmaceuticals, Personnel
Medgenics, TARGT, genomic medicine

Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health

周一, 03/07/2016 - 16:02
Amarantus Diagnostics and Theranostics Health operations to consolidate into Avant Diagnostics (AVDX) Theranostics Health customer list includes 7 of the top 10 pharmaceutical companies with estimated pharma services revenue of over $1.5 million in 2015...
Diagnostics, Mergers & Acquisitions
Amarantus Diagnostics, Avant Diagnostics, Theranostics Health

Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer

周一, 03/07/2016 - 15:54
HAYWARD, Calif., March 07, 2016 -- (Healthcare Sales & Marketing Network) -- Anthera Pharmaceuticals, Inc. (ANTH) today announced the appointment of James Pennington, M.D. as interim Chief Medical Officer following the Company’s acceptance of Colin Hislop’...
Biopharmaceuticals, Personnel
Anthera Pharmaceuticals

Merus Completes Acquisition of Surgestone(R), Provames(R), Tredemine(R) and Speciafoldine(R) Rights from Sanofi

周一, 03/07/2016 - 15:50
TORONTO, March 7, 2016 -- (Healthcare Sales & Marketing Network) - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] announced today that it has completed the previously announced acquisition of rights ...
Biopharmaceuticals, Acquisitions
Merus Labs, Sanofi, Surgestone, Provames, Tredemine, Speciafoldine

Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases

周一, 03/07/2016 - 13:28
Now Allows Total of 36 Patients for Skin Regeneration Treatment With ReCell(R) NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company speciali...
Regenerative Medicine, Wound Care, Dermatology, FDA
Avita Medical, ReCell, Regenerative Epithelial Suspension

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong